BMRN vs MDLZ · P/E 40, rev $1.76B vs P/E 30, rev $38.54B
Biomarin Pharmaceutical Inc (BMRN) versus Mondelez International Inc (MDLZ) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Mondelez International Inc (MDLZ) is a confectioners company listed on NASDAQ.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported MDLZ revenue for 2025-12-31 was $38.54B. Net income was $2.45B. Revenue was up 5.8% from 2024-12-31 to 2025-12-31. MDLZ currently screens at market cap $78.12B and trailing P/E 30.1.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. MDLZ currently screens at market cap $78.12B and trailing P/E 30.1.
Not investment advice. Open the BMRN and MDLZ stock pages for the full models.
Not investment advice.